

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of tolerance induction (GO:0002643) | 9.91303331 |
| 2 | regulation of chronic inflammatory response (GO:0002676) | 8.01343056 |
| 3 | heterotypic cell-cell adhesion (GO:0034113) | 7.39388841 |
| 4 | sperm capacitation (GO:0048240) | 7.39298247 |
| 5 | kynurenine metabolic process (GO:0070189) | 6.35127082 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.07298103 |
| 7 | leukocyte aggregation (GO:0070486) | 6.01294148 |
| 8 | tolerance induction (GO:0002507) | 5.92282785 |
| 9 | positive regulation of type 2 immune response (GO:0002830) | 5.84985770 |
| 10 | single fertilization (GO:0007338) | 5.63337032 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.60010071 |
| 12 | negative regulation of interleukin-10 production (GO:0032693) | 5.44483106 |
| 13 | regulation of type 2 immune response (GO:0002828) | 5.29230756 |
| 14 | indole-containing compound catabolic process (GO:0042436) | 5.15936285 |
| 15 | indolalkylamine catabolic process (GO:0046218) | 5.15936285 |
| 16 | tryptophan catabolic process (GO:0006569) | 5.15936285 |
| 17 | positive thymic T cell selection (GO:0045059) | 5.06334673 |
| 18 | negative regulation of type 2 immune response (GO:0002829) | 5.00945398 |
| 19 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.73170288 |
| 20 | lymphocyte costimulation (GO:0031294) | 4.71979573 |
| 21 | negative thymic T cell selection (GO:0045060) | 4.71135197 |
| 22 | T cell costimulation (GO:0031295) | 4.63668454 |
| 23 | sequestering of actin monomers (GO:0042989) | 4.62880910 |
| 24 | negative T cell selection (GO:0043383) | 4.55335312 |
| 25 | thymic T cell selection (GO:0045061) | 4.53954563 |
| 26 | cellular response to interleukin-15 (GO:0071350) | 4.50361424 |
| 27 | behavioral response to nicotine (GO:0035095) | 4.47871789 |
| 28 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.44267193 |
| 29 | negative regulation of T cell mediated immunity (GO:0002710) | 4.26108700 |
| 30 | regulation of gamma-delta T cell activation (GO:0046643) | 4.26012447 |
| 31 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.19122363 |
| 32 | tryptophan metabolic process (GO:0006568) | 4.17923006 |
| 33 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.11277953 |
| 34 | fucose catabolic process (GO:0019317) | 4.07013611 |
| 35 | L-fucose metabolic process (GO:0042354) | 4.07013611 |
| 36 | L-fucose catabolic process (GO:0042355) | 4.07013611 |
| 37 | response to interleukin-15 (GO:0070672) | 4.00470586 |
| 38 | positive regulation of CREB transcription factor activity (GO:0032793) | 3.99710068 |
| 39 | T cell receptor signaling pathway (GO:0050852) | 3.93953177 |
| 40 | activated T cell proliferation (GO:0050798) | 3.92015145 |
| 41 | negative regulation of interleukin-8 production (GO:0032717) | 3.87187118 |
| 42 | positive T cell selection (GO:0043368) | 3.86483401 |
| 43 | negative regulation of telomere maintenance (GO:0032205) | 3.85316604 |
| 44 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.84547433 |
| 45 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.81292691 |
| 46 | T cell selection (GO:0045058) | 3.69348575 |
| 47 | DNA deamination (GO:0045006) | 3.67713660 |
| 48 | negative regulation of T cell apoptotic process (GO:0070233) | 3.62517329 |
| 49 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.54410749 |
| 50 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.54410749 |
| 51 | defense response to bacterium (GO:0042742) | 3.52478250 |
| 52 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.52084889 |
| 53 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.51123204 |
| 54 | fertilization (GO:0009566) | 3.50195099 |
| 55 | positive regulation of defense response to virus by host (GO:0002230) | 3.49777258 |
| 56 | regulation of defense response to virus by virus (GO:0050690) | 3.42095375 |
| 57 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.41461821 |
| 58 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.40488408 |
| 59 | cellular response to type I interferon (GO:0071357) | 3.38865204 |
| 60 | type I interferon signaling pathway (GO:0060337) | 3.38865204 |
| 61 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.37062937 |
| 62 | response to type I interferon (GO:0034340) | 3.35615820 |
| 63 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.34220237 |
| 64 | amine catabolic process (GO:0009310) | 3.32148200 |
| 65 | cellular biogenic amine catabolic process (GO:0042402) | 3.32148200 |
| 66 | protein import into peroxisome matrix (GO:0016558) | 3.26325107 |
| 67 | regulation of respiratory burst (GO:0060263) | 3.21264423 |
| 68 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.20830360 |
| 69 | negative regulation of B cell mediated immunity (GO:0002713) | 3.20830360 |
| 70 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.20542639 |
| 71 | negative regulation of cell killing (GO:0031342) | 3.20542639 |
| 72 | aromatic amino acid family catabolic process (GO:0009074) | 3.19212222 |
| 73 | negative regulation of mast cell activation (GO:0033004) | 3.18473131 |
| 74 | regulation of interleukin-13 production (GO:0032656) | 3.16814970 |
| 75 | negative regulation of adaptive immune response (GO:0002820) | 3.16637540 |
| 76 | rRNA catabolic process (GO:0016075) | 3.16117424 |
| 77 | positive regulation of lamellipodium assembly (GO:0010592) | 3.13141818 |
| 78 | negative regulation of protein oligomerization (GO:0032460) | 3.11321631 |
| 79 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.10606953 |
| 80 | positive regulation of cell-cell adhesion (GO:0022409) | 3.08739059 |
| 81 | negative regulation of interleukin-1 production (GO:0032692) | 3.07494684 |
| 82 | T cell migration (GO:0072678) | 3.07204668 |
| 83 | response to bacterium (GO:0009617) | 3.06402184 |
| 84 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.06275372 |
| 85 | adaptation of signaling pathway (GO:0023058) | 3.04794154 |
| 86 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.02389988 |
| 87 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.01341741 |
| 88 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.99549917 |
| 89 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.99549917 |
| 90 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.99549917 |
| 91 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.98465438 |
| 92 | positive regulation of interleukin-12 production (GO:0032735) | 2.97423563 |
| 93 | indolalkylamine metabolic process (GO:0006586) | 2.94559592 |
| 94 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.94293586 |
| 95 | cellular response to exogenous dsRNA (GO:0071360) | 2.93959864 |
| 96 | desmosome organization (GO:0002934) | 2.93689305 |
| 97 | regulation of B cell mediated immunity (GO:0002712) | 2.92138799 |
| 98 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.91237925 |
| 99 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.87984334 |
| 100 | maturation of 5.8S rRNA (GO:0000460) | 2.87651733 |
| 101 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.86800307 |
| 102 | positive regulation of B cell mediated immunity (GO:0002714) | 2.86800307 |
| 103 | regulation of response to interferon-gamma (GO:0060330) | 2.84344672 |
| 104 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.84109130 |
| 105 | regulation of activated T cell proliferation (GO:0046006) | 2.82775827 |
| 106 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.80249823 |
| 107 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.79248636 |
| 108 | negative regulation of endopeptidase activity (GO:0010951) | 2.78142338 |
| 109 | regulation of defense response to virus by host (GO:0050691) | 2.76304607 |
| 110 | positive regulation of histone deacetylation (GO:0031065) | 2.75455000 |
| 111 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.75141529 |
| 112 | regulation of mast cell activation (GO:0033003) | 2.73818518 |
| 113 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.73591184 |
| 114 | respiratory burst (GO:0045730) | 2.71039369 |
| 115 | negative regulation of phagocytosis (GO:0050765) | 2.70896300 |
| 116 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.69580961 |
| 117 | modulation by symbiont of host immune response (GO:0052553) | 2.69580961 |
| 118 | positive regulation by symbiont of host defense response (GO:0052509) | 2.69580961 |
| 119 | modulation by symbiont of host defense response (GO:0052031) | 2.69580961 |
| 120 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.69580961 |
| 121 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.69580961 |
| 122 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.69506354 |
| 123 | positive regulation of mast cell activation (GO:0033005) | 2.69361584 |
| 124 | interferon-gamma production (GO:0032609) | 2.67807371 |
| 125 | regulation of interleukin-10 production (GO:0032653) | 2.66539375 |
| 126 | digestion (GO:0007586) | 2.65633850 |
| 127 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.64944231 |
| 128 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.64944231 |
| 129 | negative regulation of peptidase activity (GO:0010466) | 2.64353781 |
| 130 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.63258396 |
| 131 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.63258396 |
| 132 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.62923006 |
| 133 | response to muramyl dipeptide (GO:0032495) | 2.62596926 |
| 134 | histone H3-K4 trimethylation (GO:0080182) | 2.62455137 |
| 135 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.61862521 |
| 136 | cytidine metabolic process (GO:0046087) | 2.61012605 |
| 137 | cytidine catabolic process (GO:0006216) | 2.61012605 |
| 138 | cytidine deamination (GO:0009972) | 2.61012605 |
| 139 | mannose metabolic process (GO:0006013) | 2.57888519 |
| 140 | fucosylation (GO:0036065) | 2.57762377 |
| 141 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.57557701 |
| 142 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.56770620 |
| 143 | cAMP catabolic process (GO:0006198) | 2.56529159 |
| 144 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.54376301 |
| 145 | macrophage activation involved in immune response (GO:0002281) | 2.54296246 |
| 146 | histone H3-K9 modification (GO:0061647) | 2.53466085 |
| 147 | negative regulation of interleukin-12 production (GO:0032695) | 2.53134653 |
| 148 | negative regulation of interleukin-6 production (GO:0032715) | 2.49859298 |
| 149 | defense response to protozoan (GO:0042832) | 2.48437863 |
| 150 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.47025620 |
| 151 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.45927897 |
| 152 | response to protozoan (GO:0001562) | 2.44995831 |
| 153 | cellular response to ATP (GO:0071318) | 2.43065257 |
| 154 | glycerophospholipid catabolic process (GO:0046475) | 2.42903859 |
| 155 | negative regulation of innate immune response (GO:0045824) | 2.42302472 |
| 156 | histone H3-K9 methylation (GO:0051567) | 2.42135488 |
| 157 | positive regulation of granulocyte differentiation (GO:0030854) | 2.41325510 |
| 158 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.40503523 |
| 159 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.40076535 |
| 160 | nucleotide transmembrane transport (GO:1901679) | 2.39911689 |
| 161 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.39280708 |
| 162 | regulation of cell killing (GO:0031341) | 2.38529175 |
| 163 | regulation of memory T cell differentiation (GO:0043380) | 2.38493446 |
| 164 | protein-cofactor linkage (GO:0018065) | 2.38416553 |
| 165 | seminiferous tubule development (GO:0072520) | 16.4397609 |
| 166 | regulation of T cell tolerance induction (GO:0002664) | 13.2140042 |
| 167 | positive regulation of tolerance induction (GO:0002645) | 11.4567038 |
| 168 | production of molecular mediator involved in inflammatory response (GO:0002532) | 10.5822077 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.67745633 |
| 2 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 4.82154302 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.94474233 |
| 4 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 3.93509826 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.65693619 |
| 6 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.52693608 |
| 7 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.40926234 |
| 8 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.06894199 |
| 9 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.92425214 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.80058059 |
| 11 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.73306312 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.71963070 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.67694985 |
| 14 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.54434003 |
| 15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.42025868 |
| 16 | VDR_22108803_ChIP-Seq_LS180_Human | 2.41894458 |
| 17 | MYB_26560356_Chip-Seq_TH2_Human | 2.38601765 |
| 18 | UTX_26944678_Chip-Seq_JUKART_Human | 2.35244951 |
| 19 | MYB_26560356_Chip-Seq_TH1_Human | 2.29710606 |
| 20 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.28920781 |
| 21 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.23369583 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.22070093 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.21891375 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 2.20377478 |
| 25 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.17710902 |
| 26 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.08479270 |
| 27 | * IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.05442575 |
| 28 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 2.03229391 |
| 29 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.98944177 |
| 30 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.98578506 |
| 31 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.96587974 |
| 32 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.91196015 |
| 33 | MAF_26560356_Chip-Seq_TH2_Human | 1.87365744 |
| 34 | MYC_22102868_ChIP-Seq_BL_Human | 1.86663586 |
| 35 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.85980493 |
| 36 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.84748385 |
| 37 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.84528286 |
| 38 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.83507076 |
| 39 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.82811123 |
| 40 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.81579272 |
| 41 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.78685160 |
| 42 | ERA_21632823_ChIP-Seq_H3396_Human | 1.77571162 |
| 43 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75676215 |
| 44 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.75343838 |
| 45 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.72179335 |
| 46 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.72004325 |
| 47 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.70038255 |
| 48 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.69748794 |
| 49 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.67137919 |
| 50 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.64613305 |
| 51 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.64550421 |
| 52 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.64141647 |
| 53 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.63719928 |
| 54 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.63035709 |
| 55 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.62444844 |
| 56 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.59451371 |
| 57 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.58564659 |
| 58 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.57095392 |
| 59 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.56093312 |
| 60 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.56004785 |
| 61 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.54279795 |
| 62 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 1.53976506 |
| 63 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.53497852 |
| 64 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.52231301 |
| 65 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.50234184 |
| 66 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.48460541 |
| 67 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.46595033 |
| 68 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.46084056 |
| 69 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.45545737 |
| 70 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.44433949 |
| 71 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.43705919 |
| 72 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.43518681 |
| 73 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.42635363 |
| 74 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.42183108 |
| 75 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.41464891 |
| 76 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.41292260 |
| 77 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.40651787 |
| 78 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.40574613 |
| 79 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.40222880 |
| 80 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.38656285 |
| 81 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.38382207 |
| 82 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.37023742 |
| 83 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.37015792 |
| 84 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.36312393 |
| 85 | SA1_27219007_Chip-Seq_Bcells_Human | 1.36143380 |
| 86 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.35538590 |
| 87 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.34779145 |
| 88 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.33762519 |
| 89 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.33736809 |
| 90 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.30858585 |
| 91 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29532650 |
| 92 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.29484740 |
| 93 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.29368133 |
| 94 | P68_20966046_ChIP-Seq_HELA_Human | 1.29288544 |
| 95 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.28593650 |
| 96 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.27670963 |
| 97 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.26405226 |
| 98 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.26202976 |
| 99 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.25843189 |
| 100 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 1.24173485 |
| 101 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.24171181 |
| 102 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.23082962 |
| 103 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.22680263 |
| 104 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.22459124 |
| 105 | P300_27268052_Chip-Seq_Bcells_Human | 1.21070849 |
| 106 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20160592 |
| 107 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.18733238 |
| 108 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.18406123 |
| 109 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.17794216 |
| 110 | GATA3_26560356_Chip-Seq_TH2_Human | 1.17059104 |
| 111 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12825811 |
| 112 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 1.12633842 |
| 113 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12347838 |
| 114 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.11515781 |
| 115 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.11069775 |
| 116 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.10093294 |
| 117 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.10071453 |
| 118 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.09810912 |
| 119 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09567960 |
| 120 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.09505469 |
| 121 | BCL6_25482012_ChIP-Seq_CML-JURL-MK1_Human | 1.09170421 |
| 122 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.07970977 |
| 123 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.07748861 |
| 124 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.07633395 |
| 125 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07385316 |
| 126 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.05745717 |
| 127 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.05586480 |
| 128 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.05061586 |
| 129 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.04730790 |
| 130 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.04610180 |
| 131 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.04351641 |
| 132 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.03786421 |
| 133 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.03671224 |
| 134 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03646336 |
| 135 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.03562903 |
| 136 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.03420619 |
| 137 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.02896542 |
| 138 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.02600005 |
| 139 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.01789848 |
| 140 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.01531895 |
| 141 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99760572 |
| 142 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.99020601 |
| 143 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.98570293 |
| 144 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.98197807 |
| 145 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.98136102 |
| 146 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.97921957 |
| 147 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.97824386 |
| 148 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97784824 |
| 149 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.97498177 |
| 150 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.96953283 |
| 151 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.96903950 |
| 152 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95533688 |
| 153 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.95345929 |
| 154 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.95078709 |
| 155 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.95025070 |
| 156 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.94656936 |
| 157 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.94169512 |
| 158 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.93747960 |
| 159 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.93296312 |
| 160 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.93116991 |
| 161 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.91543343 |
| 162 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.90874492 |
| 163 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.90753923 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.66038021 |
| 2 | MP0003303_peritoneal_inflammation | 3.98564484 |
| 3 | MP0003763_abnormal_thymus_physiology | 3.71247282 |
| 4 | MP0009785_altered_susceptibility_to | 3.31291216 |
| 5 | MP0002933_joint_inflammation | 3.14050992 |
| 6 | MP0001835_abnormal_antigen_presentation | 3.08943585 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.03613923 |
| 8 | MP0000685_abnormal_immune_system | 2.95678909 |
| 9 | MP0006082_CNS_inflammation | 2.83269239 |
| 10 | MP0001986_abnormal_taste_sensitivity | 2.82053443 |
| 11 | MP0002166_altered_tumor_susceptibility | 2.77119919 |
| 12 | MP0005025_abnormal_response_to | 2.70204098 |
| 13 | MP0001790_abnormal_immune_system | 2.61530795 |
| 14 | MP0005387_immune_system_phenotype | 2.61530795 |
| 15 | MP0010234_abnormal_vibrissa_follicle | 2.57001776 |
| 16 | MP0001800_abnormal_humoral_immune | 2.56562507 |
| 17 | MP0001819_abnormal_immune_cell | 2.50838738 |
| 18 | MP0001853_heart_inflammation | 2.48653413 |
| 19 | MP0002723_abnormal_immune_serum | 2.48021783 |
| 20 | MP0003724_increased_susceptibility_to | 2.45126320 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.41930760 |
| 22 | MP0002653_abnormal_ependyma_morphology | 2.37392431 |
| 23 | MP0002452_abnormal_antigen_presenting | 2.35206035 |
| 24 | MP0003436_decreased_susceptibility_to | 2.31160428 |
| 25 | MP0002006_tumorigenesis | 2.11563174 |
| 26 | MP0002405_respiratory_system_inflammati | 2.06769285 |
| 27 | MP0002419_abnormal_innate_immunity | 2.06763425 |
| 28 | MP0003300_gastrointestinal_ulcer | 2.06164417 |
| 29 | MP0002398_abnormal_bone_marrow | 2.06014152 |
| 30 | MP0005310_abnormal_salivary_gland | 2.01589305 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.99724922 |
| 32 | MP0004947_skin_inflammation | 1.97567107 |
| 33 | MP0000716_abnormal_immune_system | 1.97084168 |
| 34 | MP0004381_abnormal_hair_follicle | 1.96024771 |
| 35 | MP0005058_abnormal_lysosome_morphology | 1.93885055 |
| 36 | MP0002254_reproductive_system_inflammat | 1.85915686 |
| 37 | MP0009333_abnormal_splenocyte_physiolog | 1.85891828 |
| 38 | MP0003195_calcinosis | 1.83532872 |
| 39 | MP0003448_altered_tumor_morphology | 1.82191346 |
| 40 | MP0003329_amyloid_beta_deposits | 1.80735572 |
| 41 | MP0003172_abnormal_lysosome_physiology | 1.77397246 |
| 42 | MP0000858_altered_metastatic_potential | 1.76393165 |
| 43 | MP0001845_abnormal_inflammatory_respons | 1.74972005 |
| 44 | MP0002138_abnormal_hepatobiliary_system | 1.71776402 |
| 45 | MP0002722_abnormal_immune_system | 1.69599532 |
| 46 | MP0008877_abnormal_DNA_methylation | 1.65822157 |
| 47 | MP0000569_abnormal_digit_pigmentation | 1.58587144 |
| 48 | MP0004510_myositis | 1.57614139 |
| 49 | MP0000689_abnormal_spleen_morphology | 1.56278307 |
| 50 | MP0005451_abnormal_body_composition | 1.54082906 |
| 51 | MP0003646_muscle_fatigue | 1.52063231 |
| 52 | MP0002429_abnormal_blood_cell | 1.50277718 |
| 53 | MP0003787_abnormal_imprinting | 1.50254500 |
| 54 | MP0002148_abnormal_hypersensitivity_rea | 1.47787575 |
| 55 | MP0000703_abnormal_thymus_morphology | 1.45963159 |
| 56 | MP0005174_abnormal_tail_pigmentation | 1.44423901 |
| 57 | MP0001501_abnormal_sleep_pattern | 1.43556476 |
| 58 | MP0003866_abnormal_defecation | 1.42776155 |
| 59 | MP0008995_early_reproductive_senescence | 1.39734800 |
| 60 | MP0004130_abnormal_muscle_cell | 1.38254282 |
| 61 | MP0001533_abnormal_skeleton_physiology | 1.38209345 |
| 62 | MP0008469_abnormal_protein_level | 1.36995271 |
| 63 | MP0003136_yellow_coat_color | 1.36983678 |
| 64 | MP0003566_abnormal_cell_adhesion | 1.32847761 |
| 65 | MP0004142_abnormal_muscle_tone | 1.30878263 |
| 66 | MP0000604_amyloidosis | 1.30744431 |
| 67 | MP0002277_abnormal_respiratory_mucosa | 1.30521204 |
| 68 | MP0001851_eye_inflammation | 1.28844237 |
| 69 | MP0009278_abnormal_bone_marrow | 1.28033672 |
| 70 | MP0002876_abnormal_thyroid_physiology | 1.27907375 |
| 71 | MP0008875_abnormal_xenobiotic_pharmacok | 1.27062343 |
| 72 | MP0001968_abnormal_touch/_nociception | 1.27008210 |
| 73 | MP0002102_abnormal_ear_morphology | 1.26244681 |
| 74 | MP0005464_abnormal_platelet_physiology | 1.25510696 |
| 75 | MP0001873_stomach_inflammation | 1.24650769 |
| 76 | MP0005410_abnormal_fertilization | 1.23971634 |
| 77 | MP0001919_abnormal_reproductive_system | 1.21577128 |
| 78 | MP0009764_decreased_sensitivity_to | 1.20774149 |
| 79 | MP0001348_abnormal_lacrimal_gland | 1.20635911 |
| 80 | MP0005551_abnormal_eye_electrophysiolog | 1.20216491 |
| 81 | MP0005075_abnormal_melanosome_morpholog | 1.20136938 |
| 82 | MP0000465_gastrointestinal_hemorrhage | 1.10478869 |
| 83 | MP0003191_abnormal_cellular_cholesterol | 1.10250837 |
| 84 | MP0008961_abnormal_basal_metabolism | 1.09670325 |
| 85 | MP0002928_abnormal_bile_duct | 1.08123791 |
| 86 | MP0005023_abnormal_wound_healing | 1.08110753 |
| 87 | MP0000343_altered_response_to | 1.07882062 |
| 88 | MP0000015_abnormal_ear_pigmentation | 1.07551788 |
| 89 | MP0009763_increased_sensitivity_to | 1.05701196 |
| 90 | MP0005167_abnormal_blood-brain_barrier | 1.04295094 |
| 91 | MP0002998_abnormal_bone_remodeling | 1.00551794 |
| 92 | MP0005645_abnormal_hypothalamus_physiol | 0.99516147 |
| 93 | MP0001502_abnormal_circadian_rhythm | 0.98124347 |
| 94 | MP0002796_impaired_skin_barrier | 0.97499553 |
| 95 | MP0006292_abnormal_olfactory_placode | 0.96252505 |
| 96 | MP0002132_abnormal_respiratory_system | 0.95631244 |
| 97 | MP0009745_abnormal_behavioral_response | 0.94676526 |
| 98 | MP0005448_abnormal_energy_balance | 0.92049288 |
| 99 | MP0004043_abnormal_pH_regulation | 0.91516613 |
| 100 | MP0009046_muscle_twitch | 0.90752103 |
| 101 | MP0004742_abnormal_vestibular_system | 0.90713697 |
| 102 | MP0000003_abnormal_adipose_tissue | 0.87949129 |
| 103 | MP0004133_heterotaxia | 0.86107330 |
| 104 | MP0000470_abnormal_stomach_morphology | 0.85906432 |
| 105 | MP0002396_abnormal_hematopoietic_system | 0.84845929 |
| 106 | MP0002089_abnormal_postnatal_growth/wei | 0.84038930 |
| 107 | MP0002095_abnormal_skin_pigmentation | 0.83048289 |
| 108 | MP0002638_abnormal_pupillary_reflex | 0.81910706 |
| 109 | MP0009765_abnormal_xenobiotic_induced | 0.81906737 |
| 110 | MP0002168_other_aberrant_phenotype | 0.80472661 |
| 111 | MP0002733_abnormal_thermal_nociception | 0.80354325 |
| 112 | MP0005389_reproductive_system_phenotype | 0.79792485 |
| 113 | MP0001216_abnormal_epidermal_layer | 0.77957113 |
| 114 | MP0001191_abnormal_skin_condition | 0.77702650 |
| 115 | MP0000249_abnormal_blood_vessel | 0.77231241 |
| 116 | MP0005423_abnormal_somatic_nervous | 0.76835022 |
| 117 | MP0005501_abnormal_skin_physiology | 0.73150165 |
| 118 | MP0009643_abnormal_urine_homeostasis | 0.72551132 |
| 119 | MP0005166_decreased_susceptibility_to | 0.72532808 |
| 120 | MP0000631_abnormal_neuroendocrine_gland | 0.71627075 |
| 121 | MP0001970_abnormal_pain_threshold | 0.71163623 |
| 122 | MP0005381_digestive/alimentary_phenotyp | 0.70605097 |
| 123 | MP0002693_abnormal_pancreas_physiology | 0.69865974 |
| 124 | MP0002064_seizures | 0.69816832 |
| 125 | MP0002272_abnormal_nervous_system | 0.69446420 |
| 126 | MP0002572_abnormal_emotion/affect_behav | 0.69441566 |
| 127 | MP0003795_abnormal_bone_structure | 0.69211507 |
| 128 | MP0003011_delayed_dark_adaptation | 0.69202998 |
| 129 | MP0000230_abnormal_systemic_arterial | 0.68986393 |
| 130 | MP0002136_abnormal_kidney_physiology | 0.68752815 |
| 131 | MP0002019_abnormal_tumor_incidence | 0.68490075 |
| 132 | MP0002063_abnormal_learning/memory/cond | 0.67046062 |
| 133 | MP0005360_urolithiasis | 0.65634152 |
| 134 | MP0001663_abnormal_digestive_system | 0.65554843 |
| 135 | MP0001661_extended_life_span | 0.64907672 |
| 136 | MP0001485_abnormal_pinna_reflex | 0.63721202 |
| 137 | MP0001881_abnormal_mammary_gland | 0.63505810 |
| 138 | MP0000477_abnormal_intestine_morphology | 0.62486083 |
| 139 | MP0005390_skeleton_phenotype | 0.61768043 |
| 140 | MP0002837_dystrophic_cardiac_calcinosis | 0.60580831 |
| 141 | MP0000427_abnormal_hair_cycle | 0.58967232 |
| 142 | MP0003959_abnormal_lean_body | 0.58016183 |
| 143 | MP0005375_adipose_tissue_phenotype | 0.57653526 |
| 144 | MP0008872_abnormal_physiological_respon | 0.54350414 |
| 145 | MP0000609_abnormal_liver_physiology | 0.53899396 |
| 146 | MP0003453_abnormal_keratinocyte_physiol | 0.52271209 |
| 147 | MP0002909_abnormal_adrenal_gland | 0.50746127 |
| 148 | MP0001765_abnormal_ion_homeostasis | 0.50420056 |
| 149 | MP0001764_abnormal_homeostasis | 0.49844692 |
| 150 | MP0002139_abnormal_hepatobiliary_system | 0.49698684 |
| 151 | MP0005636_abnormal_mineral_homeostasis | 0.47633044 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IgM deficiency (HP:0002850) | 6.46143931 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 6.04030037 |
| 3 | Recurrent bronchitis (HP:0002837) | 5.69989362 |
| 4 | Eczematoid dermatitis (HP:0000976) | 5.30958295 |
| 5 | B lymphocytopenia (HP:0010976) | 4.82812106 |
| 6 | Abnormality of B cell number (HP:0010975) | 4.82812106 |
| 7 | IgG deficiency (HP:0004315) | 4.74812164 |
| 8 | Severe combined immunodeficiency (HP:0004430) | 4.57746055 |
| 9 | Myositis (HP:0100614) | 4.57002722 |
| 10 | T lymphocytopenia (HP:0005403) | 4.39598708 |
| 11 | Stomatitis (HP:0010280) | 4.34909580 |
| 12 | Abnormality of T cell number (HP:0011839) | 4.28319609 |
| 13 | Combined immunodeficiency (HP:0005387) | 4.23121631 |
| 14 | Pustule (HP:0200039) | 3.91693227 |
| 15 | Abnormality of T cells (HP:0002843) | 3.87301423 |
| 16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.79420814 |
| 17 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.77644278 |
| 18 | Increased IgM level (HP:0003496) | 3.76126603 |
| 19 | Recurrent sinusitis (HP:0011108) | 3.74221777 |
| 20 | Congenital stationary night blindness (HP:0007642) | 3.73023403 |
| 21 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.69348147 |
| 22 | Recurrent abscess formation (HP:0002722) | 3.65315347 |
| 23 | IgA deficiency (HP:0002720) | 3.54812790 |
| 24 | Lymphopenia (HP:0001888) | 3.46711234 |
| 25 | Gastrointestinal stroma tumor (HP:0100723) | 3.46422078 |
| 26 | Abnormality of macrophages (HP:0004311) | 3.40016501 |
| 27 | Abnormality of T cell physiology (HP:0011840) | 3.33479140 |
| 28 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.31488936 |
| 29 | Abnormality of midbrain morphology (HP:0002418) | 3.28155377 |
| 30 | Molar tooth sign on MRI (HP:0002419) | 3.28155377 |
| 31 | Recurrent fungal infections (HP:0002841) | 3.28147184 |
| 32 | Bronchitis (HP:0012387) | 3.27071993 |
| 33 | Pancreatic cysts (HP:0001737) | 3.25881408 |
| 34 | Stomach cancer (HP:0012126) | 3.17727587 |
| 35 | Abnormal drinking behavior (HP:0030082) | 3.16237449 |
| 36 | Polydipsia (HP:0001959) | 3.16237449 |
| 37 | Orchitis (HP:0100796) | 3.16201764 |
| 38 | Recurrent cutaneous fungal infections (HP:0011370) | 3.14738459 |
| 39 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.14738459 |
| 40 | Obstructive lung disease (HP:0006536) | 3.11911151 |
| 41 | Chronic obstructive pulmonary disease (HP:0006510) | 3.11911151 |
| 42 | Vasculitis (HP:0002633) | 3.08239156 |
| 43 | Neoplasm of the heart (HP:0100544) | 3.07228962 |
| 44 | Erythema (HP:0010783) | 3.02805376 |
| 45 | Myocardial infarction (HP:0001658) | 3.01886413 |
| 46 | Vacuolated lymphocytes (HP:0001922) | 3.00287445 |
| 47 | Abnormality of eosinophils (HP:0001879) | 2.97175992 |
| 48 | Optic neuritis (HP:0100653) | 2.94383239 |
| 49 | Retrobulbar optic neuritis (HP:0100654) | 2.94383239 |
| 50 | Hypoplasia of the thymus (HP:0000778) | 2.93402063 |
| 51 | Recurrent bacterial skin infections (HP:0005406) | 2.88517901 |
| 52 | Thyroiditis (HP:0100646) | 2.85107820 |
| 53 | Hypergammaglobulinemia (HP:0010702) | 2.84575549 |
| 54 | Type II lissencephaly (HP:0007260) | 2.84209683 |
| 55 | Hypochromic anemia (HP:0001931) | 2.83021975 |
| 56 | Abnormality of the renal cortex (HP:0011035) | 2.79549457 |
| 57 | Hypophosphatemic rickets (HP:0004912) | 2.76131011 |
| 58 | Recurrent skin infections (HP:0001581) | 2.73469918 |
| 59 | Nephronophthisis (HP:0000090) | 2.71426133 |
| 60 | Brushfield spots (HP:0001088) | 2.71181425 |
| 61 | Large for gestational age (HP:0001520) | 2.69835012 |
| 62 | Nasal polyposis (HP:0100582) | 2.69217565 |
| 63 | Gingivitis (HP:0000230) | 2.68958948 |
| 64 | Chronic diarrhea (HP:0002028) | 2.68815717 |
| 65 | Recurrent otitis media (HP:0000403) | 2.67723317 |
| 66 | Tubular atrophy (HP:0000092) | 2.65661433 |
| 67 | Attenuation of retinal blood vessels (HP:0007843) | 2.65546464 |
| 68 | Polar cataract (HP:0010696) | 2.64210958 |
| 69 | Leukocytosis (HP:0001974) | 2.63964993 |
| 70 | Pancreatic fibrosis (HP:0100732) | 2.63462674 |
| 71 | Emphysema (HP:0002097) | 2.56760943 |
| 72 | Genetic anticipation (HP:0003743) | 2.55624422 |
| 73 | Dry hair (HP:0011359) | 2.53579461 |
| 74 | Rib fusion (HP:0000902) | 2.52526064 |
| 75 | Amyotrophic lateral sclerosis (HP:0007354) | 2.52357404 |
| 76 | Urticaria (HP:0001025) | 2.48362111 |
| 77 | Mediastinal lymphadenopathy (HP:0100721) | 2.48290618 |
| 78 | Encephalitis (HP:0002383) | 2.45939621 |
| 79 | Autoimmune hemolytic anemia (HP:0001890) | 2.41116984 |
| 80 | Panhypogammaglobulinemia (HP:0003139) | 2.38397883 |
| 81 | Joint swelling (HP:0001386) | 2.38242851 |
| 82 | Abnormality of the renal medulla (HP:0100957) | 2.37599571 |
| 83 | Inability to walk (HP:0002540) | 2.37012313 |
| 84 | Hyperventilation (HP:0002883) | 2.35492092 |
| 85 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.34959517 |
| 86 | Abnormality of the pons (HP:0007361) | 2.34504026 |
| 87 | Pulmonary infiltrates (HP:0002113) | 2.33692727 |
| 88 | Cystic liver disease (HP:0006706) | 2.32681077 |
| 89 | Chronic otitis media (HP:0000389) | 2.32465333 |
| 90 | True hermaphroditism (HP:0010459) | 2.31261084 |
| 91 | Anorexia (HP:0002039) | 2.29759408 |
| 92 | Abnormality of the nasal mucosa (HP:0000433) | 2.29503382 |
| 93 | Skin rash (HP:0000988) | 2.29021498 |
| 94 | Chronic hepatic failure (HP:0100626) | 2.27286432 |
| 95 | Progressive cerebellar ataxia (HP:0002073) | 2.26835767 |
| 96 | Increased density of long bones (HP:0006392) | 2.26832067 |
| 97 | Hemoptysis (HP:0002105) | 2.25571168 |
| 98 | Polyuria (HP:0000103) | 2.25125805 |
| 99 | Protruding tongue (HP:0010808) | 2.25070621 |
| 100 | Patellar aplasia (HP:0006443) | 2.19757779 |
| 101 | Severe muscular hypotonia (HP:0006829) | 2.19411429 |
| 102 | Abnormal biliary tract physiology (HP:0012439) | 2.19290692 |
| 103 | Bile duct proliferation (HP:0001408) | 2.19290692 |
| 104 | Asplenia (HP:0001746) | 2.18468200 |
| 105 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.17442433 |
| 106 | Duplicated collecting system (HP:0000081) | 2.17000821 |
| 107 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.13747210 |
| 108 | Hypoplasia of the pons (HP:0012110) | 2.12812432 |
| 109 | Meningitis (HP:0001287) | 2.12424123 |
| 110 | Clumsiness (HP:0002312) | 2.11954528 |
| 111 | Microcytic anemia (HP:0001935) | 2.10907198 |
| 112 | Gastrointestinal infarctions (HP:0005244) | 2.08446168 |
| 113 | Pendular nystagmus (HP:0012043) | 2.07797557 |
| 114 | Progressive inability to walk (HP:0002505) | 2.07720264 |
| 115 | Nuclear cataract (HP:0100018) | 2.07431657 |
| 116 | Hypertriglyceridemia (HP:0002155) | 2.07242836 |
| 117 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.07078555 |
| 118 | Recurrent pneumonia (HP:0006532) | 2.07019947 |
| 119 | Optic nerve coloboma (HP:0000588) | 2.05121524 |
| 120 | Large eyes (HP:0001090) | 2.04768925 |
| 121 | Increased serum ferritin (HP:0003281) | 2.04470838 |
| 122 | Abnormality of the renal collecting system (HP:0004742) | 2.04024069 |
| 123 | Eosinophilia (HP:0001880) | 2.03920873 |
| 124 | Cerebellar dysplasia (HP:0007033) | 2.02622554 |
| 125 | Keratoconjunctivitis sicca (HP:0001097) | 2.02597291 |
| 126 | Restrictive lung disease (HP:0002091) | 2.02254775 |
| 127 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.01787327 |
| 128 | Lissencephaly (HP:0001339) | 1.98987443 |
| 129 | Basal cell carcinoma (HP:0002671) | 1.98292715 |
| 130 | Arthralgia (HP:0002829) | 1.98029858 |
| 131 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.97363266 |
| 132 | Cheilitis (HP:0100825) | 1.96284074 |
| 133 | Abolished electroretinogram (ERG) (HP:0000550) | 1.95993587 |
| 134 | Decreased circulating renin level (HP:0003351) | 1.95884689 |
| 135 | Mesangial abnormality (HP:0001966) | 1.94716903 |
| 136 | Agammaglobulinemia (HP:0004432) | 1.93063793 |
| 137 | Autoimmune thrombocytopenia (HP:0001973) | 1.92963697 |
| 138 | Increased IgE level (HP:0003212) | 1.91879651 |
| 139 | Gangrene (HP:0100758) | 1.91075555 |
| 140 | Conical tooth (HP:0000698) | 1.90100668 |
| 141 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.89368461 |
| 142 | Abnormality of iron homeostasis (HP:0011031) | 1.88677271 |
| 143 | Hypoplastic iliac wings (HP:0002866) | 1.86367406 |
| 144 | Granulocytopenia (HP:0001913) | 1.86008550 |
| 145 | Hepatosplenomegaly (HP:0001433) | 1.85795353 |
| 146 | Abnormality of the lumbar spine (HP:0100712) | 1.85123264 |
| 147 | Renal cortical cysts (HP:0000803) | 1.84900001 |
| 148 | Abnormal number of erythroid precursors (HP:0012131) | 1.83910061 |
| 149 | Abnormal urine output (HP:0012590) | 1.83772570 |
| 150 | Keratitis (HP:0000491) | 1.82600362 |
| 151 | Flat occiput (HP:0005469) | 1.82119153 |
| 152 | Alveolar cell carcinoma (HP:0006519) | 1.81820097 |
| 153 | Abnormality of DNA repair (HP:0003254) | 1.81590291 |
| 154 | Lymphoma (HP:0002665) | 1.80526765 |
| 155 | Vascular calcification (HP:0004934) | 1.79629937 |
| 156 | Skin ulcer (HP:0200042) | 1.78756827 |
| 157 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.78489437 |
| 158 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.78317521 |
| 159 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.78173849 |
| 160 | Choroideremia (HP:0001139) | 1.77747716 |
| 161 | Sepsis (HP:0100806) | 1.76600675 |
| 162 | Prominent nose (HP:0000448) | 1.76370460 |
| 163 | Entropion (HP:0000621) | 1.75889740 |
| 164 | Hypoalbuminemia (HP:0003073) | 1.75833877 |
| 165 | Abnormal albumin level (HP:0012116) | 1.75833877 |
| 166 | Keratoconjunctivitis (HP:0001096) | 1.75215455 |
| 167 | Pulmonary embolism (HP:0002204) | 1.74533997 |
| 168 | Absent thumb (HP:0009777) | 1.71351154 |
| 169 | Impulsivity (HP:0100710) | 1.70760222 |
| 170 | Arterial thrombosis (HP:0004420) | 1.70545747 |
| 171 | Chest pain (HP:0100749) | 1.69184656 |
| 172 | Cellulitis (HP:0100658) | 1.68364945 |
| 173 | Macroglossia (HP:0000158) | 1.68000815 |
| 174 | Bulbous nose (HP:0000414) | 1.67186133 |
| 175 | Birth length less than 3rd percentile (HP:0003561) | 1.66538217 |
| 176 | Hypoproteinemia (HP:0003075) | 1.64402985 |
| 177 | Abnormal platelet volume (HP:0011876) | 1.63256191 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDR | 4.58758133 |
| 2 | TXK | 4.20575579 |
| 3 | MAP3K12 | 4.13463317 |
| 4 | MAP4K1 | 3.57136602 |
| 5 | FGFR4 | 3.41498985 |
| 6 | TESK2 | 3.31074008 |
| 7 | BLK | 3.22836061 |
| 8 | ZAP70 | 3.13920864 |
| 9 | ADRBK2 | 2.89393822 |
| 10 | WNK4 | 2.56630478 |
| 11 | FRK | 2.52666240 |
| 12 | TBK1 | 2.35137666 |
| 13 | IRAK4 | 2.32831456 |
| 14 | ITK | 2.32535066 |
| 15 | TESK1 | 2.28876464 |
| 16 | MAP2K6 | 2.25700938 |
| 17 | ERN1 | 2.24337793 |
| 18 | IKBKE | 2.21105582 |
| 19 | MST4 | 2.06852917 |
| 20 | EPHB1 | 1.90075652 |
| 21 | LCK | 1.86567221 |
| 22 | CSK | 1.79153829 |
| 23 | LRRK2 | 1.76597889 |
| 24 | BTK | 1.73378382 |
| 25 | MYLK | 1.72188588 |
| 26 | TYK2 | 1.68999370 |
| 27 | FGFR3 | 1.68982895 |
| 28 | HCK | 1.64617216 |
| 29 | DAPK2 | 1.58940977 |
| 30 | SYK | 1.58342797 |
| 31 | MAPK15 | 1.57663525 |
| 32 | STK10 | 1.54619819 |
| 33 | MAP4K2 | 1.51050324 |
| 34 | CAMKK2 | 1.50282065 |
| 35 | TNK2 | 1.48259171 |
| 36 | INSRR | 1.46133858 |
| 37 | MAP3K7 | 1.45806947 |
| 38 | TEC | 1.43498944 |
| 39 | CAMKK1 | 1.42936936 |
| 40 | PASK | 1.38557263 |
| 41 | BMPR1B | 1.31873470 |
| 42 | SIK1 | 1.30626136 |
| 43 | LIMK1 | 1.24469881 |
| 44 | MAP2K3 | 1.24342888 |
| 45 | JAK1 | 1.23492958 |
| 46 | MAPK13 | 1.22941196 |
| 47 | GRK6 | 1.22452753 |
| 48 | FGFR2 | 1.21931581 |
| 49 | JAK3 | 1.15794581 |
| 50 | GRK1 | 1.13445162 |
| 51 | ILK | 1.12059142 |
| 52 | CSNK1G2 | 1.11700237 |
| 53 | WNK3 | 1.08563619 |
| 54 | MAP3K11 | 1.06342427 |
| 55 | MAP3K14 | 1.03080859 |
| 56 | CHUK | 1.01762545 |
| 57 | PRKD2 | 1.01523534 |
| 58 | MAP3K13 | 1.01172060 |
| 59 | FGFR1 | 1.00984367 |
| 60 | PKN2 | 0.99845452 |
| 61 | MARK2 | 0.97581403 |
| 62 | MAP2K2 | 0.97068645 |
| 63 | PINK1 | 0.91101442 |
| 64 | TAOK3 | 0.90249677 |
| 65 | INSR | 0.89666638 |
| 66 | FYN | 0.88887269 |
| 67 | SIK2 | 0.88495100 |
| 68 | ADRBK1 | 0.86124600 |
| 69 | PAK4 | 0.85854021 |
| 70 | CDC42BPA | 0.85152765 |
| 71 | STK11 | 0.84364365 |
| 72 | PRKCH | 0.83102974 |
| 73 | MAPK12 | 0.82872602 |
| 74 | STK24 | 0.82636450 |
| 75 | IRAK3 | 0.81567939 |
| 76 | RPS6KA6 | 0.79101462 |
| 77 | ZAK | 0.78327427 |
| 78 | TLK1 | 0.77832691 |
| 79 | PRKCQ | 0.77823556 |
| 80 | MATK | 0.76813098 |
| 81 | ROCK1 | 0.76344157 |
| 82 | LYN | 0.75927345 |
| 83 | HIPK2 | 0.74975806 |
| 84 | TRIB3 | 0.73516922 |
| 85 | TAOK1 | 0.73472679 |
| 86 | WNK1 | 0.72510666 |
| 87 | SIK3 | 0.72370306 |
| 88 | MAPK7 | 0.72297242 |
| 89 | KIT | 0.71395425 |
| 90 | MAPKAPK5 | 0.70633993 |
| 91 | NUAK1 | 0.69926690 |
| 92 | DAPK3 | 0.68828241 |
| 93 | MAPK11 | 0.68101702 |
| 94 | EPHA2 | 0.67434725 |
| 95 | DMPK | 0.65403221 |
| 96 | PTK2B | 0.65193282 |
| 97 | CSNK1G3 | 0.63318289 |
| 98 | CSNK1A1L | 0.60976335 |
| 99 | PAK3 | 0.59880386 |
| 100 | MUSK | 0.58761475 |
| 101 | MAP2K4 | 0.58647847 |
| 102 | CAMK1D | 0.58512603 |
| 103 | EIF2AK3 | 0.57553657 |
| 104 | PDGFRB | 0.57424507 |
| 105 | MAPKAPK3 | 0.56610248 |
| 106 | DYRK2 | 0.55311112 |
| 107 | FES | 0.54280247 |
| 108 | FGR | 0.54106021 |
| 109 | NME1 | 0.53619071 |
| 110 | TGFBR1 | 0.52168260 |
| 111 | PRKD1 | 0.51773007 |
| 112 | BCKDK | 0.50392440 |
| 113 | CDK4 | 0.50016517 |
| 114 | GRK7 | 0.49922368 |
| 115 | IRAK2 | 0.49656149 |
| 116 | TYRO3 | 0.49560789 |
| 117 | RIPK4 | 0.49471579 |
| 118 | PRKCZ | 0.46474844 |
| 119 | PRKCG | 0.46391819 |
| 120 | CSNK1G1 | 0.46282626 |
| 121 | IGF1R | 0.46005764 |
| 122 | CAMK4 | 0.45870624 |
| 123 | FER | 0.45796662 |
| 124 | MKNK2 | 0.45298004 |
| 125 | CDK19 | 0.44841737 |
| 126 | MAP3K4 | 0.42744554 |
| 127 | CAMK1 | 0.42678186 |
| 128 | PRKAA2 | 0.42014600 |
| 129 | PRKG2 | 0.41912719 |
| 130 | SRC | 0.40962303 |
| 131 | RET | 0.40376250 |
| 132 | OXSR1 | 0.40337409 |
| 133 | ALK | 0.39685703 |
| 134 | ACVR1B | 0.39394852 |
| 135 | RPS6KL1 | 0.38560649 |
| 136 | RPS6KC1 | 0.38560649 |
| 137 | PTK2 | 0.37463465 |
| 138 | PRKCD | 0.36465431 |
| 139 | IKBKB | 0.36134481 |
| 140 | TGFBR2 | 0.36118082 |
| 141 | ABL1 | 0.33368887 |
| 142 | IRAK1 | 0.33263057 |
| 143 | PDK1 | 0.31661740 |
| 144 | MARK3 | 0.31547471 |
| 145 | MAPKAPK2 | 0.30691670 |
| 146 | NME2 | 0.29839133 |
| 147 | NLK | 0.28371392 |
| 148 | NEK2 | 0.27707035 |
| 149 | NTRK2 | 0.27028103 |
| 150 | JAK2 | 0.26135951 |
| 151 | ROCK2 | 0.24720433 |
| 152 | CSF1R | 0.23834832 |
| 153 | EGFR | 0.23748203 |
| 154 | TTN | 0.23391398 |
| 155 | PDGFRA | 0.21496307 |
| 156 | DAPK1 | 0.21023323 |
| 157 | CDK6 | 0.19013265 |
| 158 | LMTK2 | 0.17744788 |
| 159 | MAPK3 | 0.15987054 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.71816872 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.73956128 |
| 3 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.46351300 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.31339461 |
| 5 | Glutathione metabolism_Homo sapiens_hsa00480 | 3.02864210 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.90618363 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.65090595 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.59966000 |
| 9 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.53970300 |
| 10 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.51665743 |
| 11 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.39273860 |
| 12 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.23919391 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 2.22023703 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 2.08631172 |
| 15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.08147192 |
| 16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.07326233 |
| 17 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 2.06985432 |
| 18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.01791404 |
| 19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.99992189 |
| 20 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.91740199 |
| 21 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.82448888 |
| 22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.81297644 |
| 23 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.81009757 |
| 24 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.79236498 |
| 25 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.56895449 |
| 26 | Asthma_Homo sapiens_hsa05310 | 1.56296406 |
| 27 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.54361519 |
| 28 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.54285263 |
| 29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.49471735 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.45275805 |
| 31 | Phototransduction_Homo sapiens_hsa04744 | 1.44992787 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.41609898 |
| 33 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.39885460 |
| 34 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.39745624 |
| 35 | ABC transporters_Homo sapiens_hsa02010 | 1.38162839 |
| 36 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.32464798 |
| 37 | Viral myocarditis_Homo sapiens_hsa05416 | 1.28661875 |
| 38 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.26598362 |
| 39 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.24613023 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 1.23564234 |
| 41 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.22213272 |
| 42 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.17976335 |
| 43 | Hepatitis C_Homo sapiens_hsa05160 | 1.13090734 |
| 44 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.12683614 |
| 45 | Morphine addiction_Homo sapiens_hsa05032 | 1.12368631 |
| 46 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.10790510 |
| 47 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.10461553 |
| 48 | Lysosome_Homo sapiens_hsa04142 | 1.08404271 |
| 49 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.07329517 |
| 50 | Sulfur relay system_Homo sapiens_hsa04122 | 1.07031563 |
| 51 | Proteasome_Homo sapiens_hsa03050 | 1.06991534 |
| 52 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.06891022 |
| 53 | Protein export_Homo sapiens_hsa03060 | 1.06287492 |
| 54 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.06236214 |
| 55 | Ribosome_Homo sapiens_hsa03010 | 1.04743194 |
| 56 | Nicotine addiction_Homo sapiens_hsa05033 | 1.03644484 |
| 57 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.02945753 |
| 58 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.90069981 |
| 59 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.88524723 |
| 60 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.88445226 |
| 61 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.88118212 |
| 62 | Homologous recombination_Homo sapiens_hsa03440 | 0.87616898 |
| 63 | Tuberculosis_Homo sapiens_hsa05152 | 0.85933071 |
| 64 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.85349536 |
| 65 | Salmonella infection_Homo sapiens_hsa05132 | 0.83226192 |
| 66 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.81773065 |
| 67 | Taste transduction_Homo sapiens_hsa04742 | 0.81271925 |
| 68 | RNA degradation_Homo sapiens_hsa03018 | 0.80162924 |
| 69 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.79975509 |
| 70 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.79653665 |
| 71 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.77364363 |
| 72 | RNA polymerase_Homo sapiens_hsa03020 | 0.76328369 |
| 73 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.75370132 |
| 74 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.74463481 |
| 75 | Hepatitis B_Homo sapiens_hsa05161 | 0.73880246 |
| 76 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.72100383 |
| 77 | Olfactory transduction_Homo sapiens_hsa04740 | 0.71504456 |
| 78 | Other glycan degradation_Homo sapiens_hsa00511 | 0.71482314 |
| 79 | Platelet activation_Homo sapiens_hsa04611 | 0.70237855 |
| 80 | Influenza A_Homo sapiens_hsa05164 | 0.67764667 |
| 81 | Malaria_Homo sapiens_hsa05144 | 0.65237939 |
| 82 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.64376210 |
| 83 | Legionellosis_Homo sapiens_hsa05134 | 0.63583419 |
| 84 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.60162781 |
| 85 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.58897790 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57001692 |
| 87 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.56332557 |
| 88 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.55356777 |
| 89 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.55292669 |
| 90 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.54834909 |
| 91 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.54690703 |
| 92 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53371874 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51257938 |
| 94 | Pertussis_Homo sapiens_hsa05133 | 0.51068766 |
| 95 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.49534031 |
| 96 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.49428258 |
| 97 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.49250318 |
| 98 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.49226193 |
| 99 | HTLV-I infection_Homo sapiens_hsa05166 | 0.49119758 |
| 100 | Insulin secretion_Homo sapiens_hsa04911 | 0.48536281 |
| 101 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47863057 |
| 102 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.46111388 |
| 103 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.45629523 |
| 104 | Basal transcription factors_Homo sapiens_hsa03022 | 0.45013118 |
| 105 | Apoptosis_Homo sapiens_hsa04210 | 0.44891074 |
| 106 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.44254405 |
| 107 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.43757252 |
| 108 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.43294604 |
| 109 | Lysine degradation_Homo sapiens_hsa00310 | 0.43185681 |
| 110 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.41665983 |
| 111 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.41608457 |
| 112 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.41147586 |
| 113 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.40143191 |
| 114 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.39823520 |
| 115 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.39536531 |
| 116 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.39502999 |
| 117 | Endocytosis_Homo sapiens_hsa04144 | 0.38652838 |
| 118 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38547459 |
| 119 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.38397984 |
| 120 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.35714809 |
| 121 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.35384940 |
| 122 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.31741929 |
| 123 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.29371035 |
| 124 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.26830387 |
| 125 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.26171434 |
| 126 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.24699703 |
| 127 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.22827113 |
| 128 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22485099 |
| 129 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.21175287 |
| 130 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.17094466 |
| 131 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.17087473 |
| 132 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.15572977 |
| 133 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.13897876 |
| 134 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.13070625 |
| 135 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.11784346 |
| 136 | Phagosome_Homo sapiens_hsa04145 | 0.11494536 |
| 137 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.11272897 |
| 138 | Salivary secretion_Homo sapiens_hsa04970 | 0.10672813 |
| 139 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.10391620 |
| 140 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.09633133 |
| 141 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.08923763 |
| 142 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.07305790 |
| 143 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.07304608 |

